MetaCap

Axogen Statistics

NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

55.75-0.60 (-1.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Axogen by the numbers

Axogen has a market capitalization of $3.33 billion based on 59.73M shares outstanding. With trailing EPS of $-0.63, Axogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.7% above its 50-day average and 35.8% above its 200-day average.

Average daily trading volume is 1.57M shares, or about $87.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AXGN valuation vs. peer median

AXGN compared with the median of 8 peer companies
MetricAXGNPeer medianDifference
Market cap$3.33B$889.19M+274%
Forward P/E79.019.2+312%
Avg. volume1.57M408.47K+285%

Peer median across 8 companies: TMDX, LIVN, CNMD, CBLL, INMD, CV, ELMD, FOCL.

Valuation

Price / sales (latest FY)
14.79
EPS (TTM)
$-0.63

Price and trading

Previous close
56.35
Open
55.71
Day range
55.03 – 56.91
52-week range
26.92 – 59.72
52-week change
+107.48%
Beta
—
Volume
875.45K

Dividends and events

Annual dividend
None
Next earnings date
Oct 28, 2026

Additional statistics

Market Cap
3.33B
Forward Pe
79.03
Eps
-0.63
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
59.72
Week52 Low
26.92
Avg Volume
1.57M
Shares Outstanding
59.73M
Ma50
44.34
Ma200
41.06
Earnings Date
Oct 28, 2026
Pct From52w High
-6.65%
Pct From52w Low
107.10%

Related